정규장
로그인 회원가입
HCA
HCA Healthcare Inc
7월 27일 9:40 AM ET (한국 7/27 22:40)
$382.19
+5.69 ▲ +1.51%

에이치씨에이 헬스케어(HCA) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$84.8B
미드캡
P/E
12.8
저평가 구간
배당수익률
0.73%
52주 위치
23%
저점 +16% · 고점 -31%
애널리스트
매수
C
Fundamental health
vs. Medical Care Facilities
수익성
Top 28%
성장
Top 66%
밸류에이션
Top 64%
재무 안정
Top 78%
💰 Is this stock pricier than usual right now?
Compared to this company's own recent 5년 (not other companies).
Very cheap
Cheap
Typical
Pricey
Very pricey
Simply put — what you pay today to own $1 of this company's yearly earnings is 13원. Over the past 5년, it usually traded around 14원. On the cheaper side versus its own history.
Pricy doesn't mean bad — it means expectations are already baked in.
Index S&P 500P/E 12.8EPS (ttm) 29.87Insider Own 32.38%Shs Outstand 221.8MPerf Week 2.97%
Market Cap 84.78BForward P/E 11.62EPS next Y 9.66%Insider Trans -0.08%Shs Float 150.0MPerf Month -1.44%
Enterprise Value 136.89BPEG 1.27EPS next Q 7.1Inst Own 61.93%Short Float 3.57%Perf Quarter -19.37%
Income 6.84BP/S 1.09EPS this Y 6.36%Inst Trans -1.64%Short Ratio 3.25Perf Half Y -18.04%
Sales 78.01BP/B -EPS next 5Y 9.14%ROA 11.21%Short Interest 5.35MPerf YTD -18.14%
Book/sh -28.32P/C 79.69EPS past 3/5Y 13.94% 20.99%ROE -52W High -31.33% ($556.52)Perf Year 11.92%
Cash/sh 4.8P/FCF 10.7Sales past 3/5Y 7.87% 7.97%ROIC 19.41%52W Low 15.82% ($330.00)Perf 3Y 34.02%
Dividend Est. $2.79 (0.73%)EV/EBITDA 8.79EPS Y/Y TTM 29.32%Gross Margin 15.35%Volatility(W/M) 2.46% 2.93%Perf 5Y 53.82%
Dividend TTM 3EV/Sales 1.75Sales Y/Y TTM 7.31%Oper. Margin 15.35%ATR (14) 13.2Perf 10Y 375.66%
Dividend Ex-Date 2026/6/16Quick Ratio 0.75EPS Q/Q 11.58%Profit Margin 8.77%RSI (14) 47.34Recom 2.04
Dividend Gr. 3/5Y 8.74% 46.28%Current Ratio 0.83Sales Q/Q 8.73%SMA20 -2.11% ($390.43)Beta 1.11Target Price $473.7
Payout 10.17%Debt/Eq -Earnings 2026/7/24SMA50 -1.75% ($389)Rel Volume 1.64Prev Close $376.5
Employees 320000LT Debt/Eq -EPS/Sales Surpr. 0.37% 2.4%SMA200 -16.51% ($457.77)Avg Volume(3M) 1.65MPrice $382.19
IPO 2011/3/10Option/Short Yes/YesTrades 41672Volume 2,700,143Change 1.51%
Quarterly earnings trend SEC filings · USD
24.6
24.9
24.12*
25.3
25.6
25.9
25.12*
26.3
Revenue Net income 최근 분기: 매출 $19.1B (YoY +4%) · 순이익 $1.6B (YoY +1%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 HCA Healthcare Inc (HCA) Investment Analysis

What kind of company is HCA Healthcare Inc?

에이치씨에이 헬스케어(HCA) 성장주
Healthcare · Medical Care Facilities
Top 195 by Market Cap — Large-Cap

🏥 A leading group in U.S. healthcare facility operations. Founded in 1968 and headquartered in Nashville, Tennessee, the company operates a comprehensive network of healthcare facilities, including hospitals, outpatient centers, and emergency care services across a broad footprint.

Learn more about HCA Healthcare Inc →
Market Cap
$84.8B
Approx. KRW 116 trillion
⚖️ 29% of Samsung Electronics
Market Cap Rank195
Employees320,000people
IPO2011/03/10
Current Price$382.19 ≈ 523,600원
📌 S&P 500 · NYSE · USA

Key Events

⏰ Upcoming events
🔔 Earnings release
The next release date has not been announced yet.
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 7월 24일 (금) · 장 시작 전 EPS +0.4% 매출 +2.4%
🎯 Ex-div 2026년 6월 16일 (화) 주당 $0.78
🔔 Earnings release 2026년 4월 24일 (금) · 장 시작 전 EPS +0.4% 매출 +0.1%
🎯 Ex-div 2026년 3월 17일 (화) 주당 $0.78

Is it profitable?

Profitability healthy
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
15.3%
✓ 우수
My positionTop 25%
Low range Average High range
Medical Care Facilities Median 5.8% · Top 11%
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
8.8%
✓ 우수
My positionTop 25%
Low range Average High range
Medical Care Facilities Median 2.5% · Top 20%
💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
15.3%
✓ 평균
My positionMid-range
Low range Average High range
Medical Care Facilities Median 19.2% · Bottom 31%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROA
Annual earnings relative to total company assets
11.2%
✓ 우수
My positionTop 25%
Low range Average High range
Healthcare 대형주 Median 5.1% · Top 23%
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
19.4%
✓ 우수
My positionTop 25%
Low range Average High range
Healthcare 대형주 Median 7.4% · Top 16%
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Current Ratio
Liquid assets available to cover liabilities due within a year
0.83
✓ 부진
My positionBottom 25%
Low range Average High range
Medical Care Facilities Median 1.35
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
0.75
✓ 평균
My positionMid-range
Low range Average High range
Medical Care Facilities Median 1.19
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$473.70
현재가 대비 +23.9%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
11.62배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
PEG (성장 반영 밸류)
1.27
적정
💡 PEG 1~1.5 — 성장 대비 합리적
내년 EPS 예상 성장률
+9.7%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
5년 EPS 예상 연평균
+9.1%
💡 장기 성장 전망. 15% 이상이면 고성장 기업
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Average Earnings Performance
Generally in line with estimates
0
예상 상회
2
예상 부합
0
예상 하회
0%
상회 비율
+0.3%
평균 서프라이즈
2026.07.24
부합
+0.4%
2026.04.24
부합
실적 $7.15 · 예상 $7.13 +0.3%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Growth Concerns
Growth is lagging the industry average
Healthy, Balanced Growth EPS and revenue are both growing steadily — a sustainable growth profile
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+6.4%
부진
My positionBottom 25%
Low range Average High range
성장주 대형주 Median 15.4% · Bottom 10%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+9.7%
부진
My positionBottom 25%
Low range Average High range
성장주 대형주 Median 13.1% · Bottom 22%
5-Year EPS CAGR Outlook
Projected average annual EPS growth over the next 5 years
+9.1%
매우 부진
My positionBottom 5%
Low range Average High range
성장주 대형주 Median 14.9% · Bottom tier
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+13.9%
양호
My positionMid-range
Low range Average High range
성장주 대형주 Median 9.2% · Top 39%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
+21.0%
양호
My positionMid-range
Low range Average High range
성장주 대형주 Median 13.8% · Top 30%
Past 5-Year Revenue
How much revenue grew over the past 5 years
+8.0%
평균
My positionMid-range
Low range Average High range
성장주 대형주 Median 10.3% · Bottom 35%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+8.7%
평균
My positionMid-range
Low range Average High range
성장주 대형주 Median 11.2% · Bottom 37%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Underperformed the market by 14%p over 5 years
HCA +53.8% · S&P 500 +68.0%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-14.1%p
behind the market
vs Health Care (XLV)
+30.2%p
well ahead of the sector average
1-year basis
vs S&P 500
-4.5%p
roughly in line with the market
vs Health Care (XLV)
-7.8%p
slightly behind the sector average
Current position within 52-week range
Low (-15.8%p) High (-31.3%p)
Current price is 15.8% above the 52-week low and 31.3% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-33.7%
Annualized volatility
33.2%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-24
Downtrend zone

Current price $382.19 below the midline ($390.41). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴
Current diagnosis · 2026-07-24
Bearish momentum holding

MACD -5.423 < Signal -4.017 in negative zone + Hist negative (-1.406). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-24
Bearish zone

RSI 47.3 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 37.3.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry
Cheap on Vs. Earnings·Vs. Cash Flow, In line with peers on Vs. Sales
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Cheap
🧾 Vs. Sales Mid-range
💧 Vs. Cash Flow Cheap
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
12.80x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Care Facilities median 19.84x · Around the industry average
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
11.62x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Care Facilities median 18.77x · Around the industry average
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
1.09x
✓ Fair
My positionMid-range
Low range Average High range
Medical Care Facilities median 0.92x · Around the industry average
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
8.79x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Care Facilities median 11.60x · Around the industry average
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
10.70x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Care Facilities median 14.23x · Around the industry average
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$473.70 vs. current price +23.9%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Medical Care Facilities

Who owns it?

Ownership backdrop is unfavorable
Insider modest net selling -0.1% · Institutional net selling -1.6% · Short interest light 3.6% · Short interest up +1.2pp over last 90d
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-0.1%
Insiders little change
🏦 Institutions (funds & investors)
-1.6%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 61.9%
Adequate institutional weight
Healthcare 대형주 Median 91.9%
🧑‍💼 Insiders 32.4%
Founder/management large holders (strong skin-in-the-game)
Healthcare 대형주 Median 0.8%
👤 Retail investors (estimated) 5.7%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
3.6%
Low — limited short-side pressure
Healthcare 대형주 Median 3.6%
Past 90 days 📈 +1.2%p increase
Short interest days to cover
3.3 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 221.8M주
Float (tradable shares) 150.0M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding HCA

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

배당 지급 — 연 0.73%
배당보다 주가 성장에 가까운 비중
Dividend Yield
0.73%
Industry average 1.25%
Dividend Per Share
$2.79
Annualized
Payout Ratio
10%
Share of net income paid as dividends
5-Year Growth
46.3%
Annualized dividend growth
🏆 5년 연속 배당 증가
📅 지급월 3월 · 9월 · 12월
📊 총 이력 2012~2026 (35건)
연도별 배당 총액 추이
주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.
$6.50
2012
$1.40 -78.5%
2018
$1.60 +14.3%
2019
$0.77 -51.9%
2020
$1.92 +149.4%
2021
$2.24 +16.7%
2022
$2.40 +7.1%
2023
$2.64 +10.0%
2024
$2.88 +9.1%
2025
$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소
최근 배당 이력 총 35건
아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.
배당락일
주당 금액
지급일
당시 수익률
2026-03-17
$0.780
0.72%
2025-12-15
$0.720
0.60%
2025-09-16
$0.720
0.87%
2025-06-16
$0.720
0.75%
2025-03-17
$0.720
0.82%
2024-12-13
$0.660
0.84%
2024-09-16
$0.660
0.64%
2024-06-14
$0.660
0.92%
2024-03-14
$0.660
0.94%
2023-12-13
$0.600
1.10%
2023-09-14
$0.600
1.11%
2023-06-15
$0.600
1.01%
2023-03-16
$0.600
1.12%
2022-12-13
$0.560
1.12%
2022-09-15
$0.560
1.26%
2022-06-15
$0.560
1.41%
2022-03-16
$0.560
0.93%
2021-12-13
$0.480
0.90%
2021-09-15
$0.480
0.69%
2021-06-15
$0.480
0.62%
2021-03-16
$0.480
0.44%
2020-12-24
$0.268
0.47%
2020-10-29
$0.072
0.72%
2020-02-28
$0.430
1.60%
2019-11-29
$0.400
1.41%
2019-08-30
$0.400
1.58%
2019-05-31
$0.400
1.53%
2019-02-28
$0.400
1.29%
2018-11-30
$0.350
0.97%
2018-08-31
$0.350
0.78%
2018-05-31
$0.350
0.68%
2018-02-28
$0.350
0.35%
2012-12-13
$2.00
21.07%
2012-10-31
$2.50
15.84%
2012-02-14
$2.00
7.97%
* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.
💰 내가 100만원 투자한다면
연간 배당금 (세후) 6,205원
5년 누적 (세후) 7.6만원
* 환율 1,370원, 세금 15% 반영. 5년 누적은 배당 성장률 연 46.28% 가정.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
HCA This Stock
$84.8B12.8 - - 0.73% +1.5%
LLY
$1.13T43.0 36.2 107.64% 0.58% +0.9%
JNJ
$634.1B30.5 7.5 25.74% 2.04% +1.6%
ABBV
$458.2B127.9 - 15221.82% 2.65% +0.9%
UNH
$382.1B27.1 3.9 12.49% 2.15% -0.7%
MRK
$323.7B36.9 7.1 18.97% 2.49% +0.5%
Sector Avg-25.82.7-48.83%1.25%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

Derivative ETFs for HCA

Leveraged, inverse, and covered call ETFs based on the underlying asset

6 derivative ETFs based on HCA (Leverage 4 · Inverse 1 · Covered Call 1)
These are based on the same underlying asset but carry a completely different risk and return profile. Please review the warning below first.
ℹ️ What is a Derivative ETF?
These are special ETFs that amplify, reverse, or monetize the price movement of an underlying ETF or security. Leveraged ETFs aim for 2–3× the daily move, Inverse ETFs target opposite-direction returns, and Covered Call ETFs generate monthly income from option premiums.
⚠️ Caution: Long-Term Holding
Leveraged and inverse ETFs track only the daily return. With high volatility, holding them for longer periods causes cumulative volatility decay—returns diverge further from the underlying index. They are meant for short-term trading.
🧺
Deeper Analysis at the ETF Center ETF overlap, sector exposure, and X-Ray analysis tools

FAQ

What kind of company is 에이치씨에이 헬스케어(HCA)?

에이치씨에이 헬스케어(HCA) belongs to the Healthcare sector and operates in the Medical Care Facilities industry.

What is the market cap of HCA?

The market cap of HCA is approximately $84.8B, ranking 195 within its sector.

Does HCA pay dividends?

HCA has a dividend yield of approximately 0.73%, with an annual dividend of $2.79.

What is the P/E ratio of HCA?

HCA has a P/E ratio of approximately 12.8x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for HCA?

HCA has recorded a 52-week high of $556.52 and a low of $330.00.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.